Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 1, 1995Circulation

Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does higher dose intravenous amiodarone reduce arrhythmia event rates in patients with refractory, life-threatening ventricular tachyarrhythmias compared to lower doses?

Population

342 patients with refractory, recurrent hemodynamically destabilizing ventricular tachycardia or ventricular…

Comparison

Intravenous amiodarone 500 mg or 1000 mg during… vs Intravenous amiodarone 125 mg during the first…

Design

RCT, randomized, double-blind

Follow-up

48 hours

Authors

MSMelvin M. ScheinmanJLJoseph LevineDCDavid S. Cannom

Discussion

Loading...

Member takes

Overview

Supports higher-dose IV amiodarone for refractory VT/VF; confirms dose-dependent suppression in this RCT.

Structured PICO

Does higher dose intravenous amiodarone reduce arrhythmia event rates in patients with refractory, life-threatening ventricular tachyarrhythmias compared to lower doses?

P
Population
342 patients with refractory, recurrent hemodynamically destabilizing ventricular tachycardia or ventricular fibrillation, enrolled at 46 medical centers in the United States.
I
Intervention
Intravenous amiodarone 500 mg or 1000 mg during the first 24 hours, with optional 150 mg supplemental infusions for breakthrough arrhythmias.
C
Comparator
Intravenous amiodarone 125 mg during the first 24 hours, with optional 150 mg supplemental infusions.
O
Outcome
Arrhythmia event rate, time to first arrhythmic event, and number of supplemental infusions administered.hard clinical

Intravenous amiodarone demonstrates a dose-dependent efficacy in suppressing recurrent, life-threatening ventricular tachyarrhythmias, with higher doses providing greater reduction in arrhythmic events.

Cite This Study

Scheinman et al. (1995) studied this question.

synapsesocial.com/papers/6a0227fc0cec8eebbd5cc484https://doi.org/10.1161/01.cir.92.11.3264
View Full Paper
Ask AI
Bookmark
Share